CVS Health completes $8B acquisition of Signify |
Affordable Care Act dealt a blow in new judgment |
Telehealth use plummets after pandemic highs |
Johnson & Johnson scraps RSV vaccine after trial |
Nurses plan to stay in the field, but they want more progress |
UnitedHealthcare to cut back on prior authorization paperwork |
FDA approves OTC Narcan for the first time |
Congress aims to crack down on ‘zombie drug’ |
Lawsuit slams PBMs Cigna, Humana as price-fixing ‘modern gangsters’ |
Oscar Health taps former Aetna leader as CEO |
Nearly all health leaders are investing in software this year |
Healthcare groups ask CMS to create hybrid primary care payment option |
Philips launches new virtual care management services |
Amgen to lay off 450 in second round of employee cuts |
Physician compensation declined in 2022. Here are the highest-paid specialties |
Sen. Warren asks FTC to review CVS Health’s $10.6B acquisition of Oak Street Health |
CDC warns of new deadly super fungus |
Vast majority of patients want to view test results via portals |
Movers & Shakers: Sutter Health, Optum Health, Tegria make leadership changes |
Feds may soon take action against Amazon’s monopoly status |
Big bank rolls out AI claims predictor for healthcare clients |
Physician sentenced in $515M pain cream fraud scheme |
Intermountain Health launches new biotech company |
The 10 best and 10 worst states for physicians |
Quantum healthcare computing coiled for liftoff on US soil |
California partners with Civica Rx for affordable insulin |
Healthcare disparities, uninsured rate both improving |
Venerable medical journal spawns AI-focused offspring |
Should hospitals withdraw from US News & World Report rankings? |
Healthcare fraud running rampant in South Florida |
Pfizer recalls 4 million units of migraine medicine |
Prominent tech scholar: AI ‘feels like a runaway train that we’re chasing on foot’ |
These 27 drugs will be subject to Medicare rebates |
Physicians sound off on prior authorization burdens on patients |
New guidance details Medicare drug price negotiations coming in 2026 |
Toylike robot pleases counseling clients where humanoid counterpart struggles to connect |
Industry groups agree MedPAC’s inflationary update is not enough |
Most US adults with medical debt owe hospitals |
Google ups activity in 4 reaches of healthcare AI |
Sanofi to acquire Provention Bio for $2.9B |
DOJ sues Rite Aid over role in opioid epidemic |
VA first to cover new ALZ drug |
To juice medical AI adoption, try a little Aristotelian persuasion |
Pfizer to acquire Seagen for $43B |
Former CEO indicted for fake medical device implanted in patients |
FDA announces recall of two more eye drop brands |
Oversight Committee launches investigation into pharmacy benefit managers |
FDA seeking upwards of $7B for 2024 |
More financial challenges ahead for not-for-profit hospitals |
25% of parents lied about their child’s health or vaccine status during pandemic |
Ulcerative colitis AI identifies activity vs. remission, predicts future flareups |
Biden’s budget: Extend Medicare solvency through higher taxes on rich, more drug price changes |
Audit confirms former MetroHealth CEO hid unauthorized bonuses |
Best Buy makes healthcare play with Atrium Health partnership |
Radiological AI revisited from the consumer’s-eye view: ‘People need to stop calling pattern recognition artificial intelligence’ |
Top 10 hospitals in the world for 2023 |
Diabetes and obesity rates in the US are climbing |
UnityPoint Health to merge with Presbyterian Healthcare Services |
Akorn Pharmaceuticals shuts down, lays off all employees |
Academic envelope-pushers rev up biocomputing, OI and ‘intelligence in a dish’ |
FTC fines BetterHelp $7.8M, says the company 'betrayed' users for profit |
MercyOne completes acquisition of Genesis |
Walmart Health expanding with 28 locations in 2024 |
Large language AI: It’s here. It’s soon to be everywhere. Get used to it. |
ProMedica sells hospice and home care business to Gentiva for $710M |
Hackensack Meridian teams up with AI specialists for brain tumor care |
Eli Lilly caps insulin costs at $35 per month |